Wire · opportunities
LG expert AI accelerates Korea's drug discovery and industrial automation
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 14 September 2026 · Fusion42 review
LG AI Research has developed expert AI models accelerating drug discovery processes by identifying candidate substances in a day and is applying AI to reduce new drug approval times and automate industrial experimental design. Their EXAONE AI foundation models are expanding from pharmaceuticals to industrial process optimisation and finance, aiming at global markets beyond Korea.
This Wire brief sits within Fusion42's coverage of Biotech, and 2 sources have reported it.
◆ ◆ The Wire takeaway
Your biotech or industrial automation startup faces a new standard where AI can slash drug discovery and testing times from months to days. Start using or partnering with expert AI like LG’s EXAONE to avoid falling behind in speed and efficiency.
◆ Coverage
2 sources · 14 Sep 2026
◆ Related on Wire
◆ Topics